https://orcid.org/0000-0002-5021-5734
Figures & data
Figure 1 Asthma Impairment and Risk Questionnaire (AIRQ®). AIRQ® is a trademark of AstraZeneca. The AIRQ® is reproduced with permission from AstraZeneca. AstraZeneca is the copyright owner of the AIRQ®. However, third parties will be allowed to use the AIRQ® free of charge. The AIRQ® must always be used in its entirety. Except for limited reformatting, the AIRQ® may not be modified or combined with other instruments without prior written approval. The ten questions of the AIRQ® must appear verbatim, in order, and together as they are presented and not divided on separate pages. All copyright and trademark information must be maintained as it appears on the bottom of the AIRQ® and on all copies. The layout of the final authorized AIRQ® may differ slightly, but the item wording will not change.
Table 1 Sociodemographic Characteristics Overall and by AIRQ Control Group at Entry
Table 2 Relationship of AIRQ Score with Patient Self-Perception of Asthma Control (N = 1108)
Table 3 Correlations of AIRQ Score with HRQoL and Barriers to Treatment Adherence
Figure 2 Mean (± SD) SGRQ total and component scores by AIRQ control group.
Figure 3 Mean (± SD) mini-AQLQ total and domain scores by AIRQ control group.
Figure 4 Continued.
Figure 4 Relation of AIRQ and AAAQ thresholds for barriers to treatment adherence (A) AIRQ score and barriers to treatment adherence and (B) AIRQ control group and barriers to treatment adherencea. aThe analysis was performed only for those items in which mean AIRQ score differed for patients who did or did not meet the cut-off threshold score of an adherence-to-treatment barrier. The statements “I follow my asthma medication plan” and “I forget to take at least 1 dose of my inhaled steroid each day” were not assessed because the mean score was not statistically significantly different.
